Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status

SIMPLE SUMMARY: Prostate cancer is the most prevalent male cancer. It poses a survival risk if it spreads and fails treatment. In search of fresh insight into lethal prostate cancers, we examined failures in cancer defence systems operated by the key anticancer protein p53. Normally, levels of p53 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mejía-Hernández, Javier Octavio, Raghu, Dinesh, Caramia, Franco, Clemons, Nicholas, Fujihara, Kenji, Riseborough, Thomas, Teunisse, Amina, Jochemsen, Aart G., Abrahmsén, Lars, Blandino, Giovanni, Russo, Andrea, Gamell, Cristina, Fox, Stephen B., Mitchell, Catherine, Takano, Elena A., Byrne, David, Miranda, Panimaya Jeffreena, Saleh, Reem, Thorne, Heather, Sandhu, Shahneen, Williams, Scott G., Keam, Simon P., Haupt, Ygal, Haupt, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405814/
https://www.ncbi.nlm.nih.gov/pubmed/36010941
http://dx.doi.org/10.3390/cancers14163947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405814/
https://www.ncbi.nlm.nih.gov/pubmed/36010941
http://dx.doi.org/10.3390/cancers14163947

Ejemplares similares